484 related articles for article (PubMed ID: 16441985)
1. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
[TBL] [Abstract][Full Text] [Related]
2. Low-level quinolone-resistance in multi-drug resistant typhoid.
Mirza SH; Khan MA
J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
[TBL] [Abstract][Full Text] [Related]
3. Nalidixic acid screening test in detection of decreased fluoroquinolone susceptibility in Salmonella typhi isolated from blood.
Zafar A; Ibrahim NG; Ahsan T; Abbas Z; Zaidi A; Hasan R
J Coll Physicians Surg Pak; 2005 Jul; 15(7):413-7. PubMed ID: 16197870
[TBL] [Abstract][Full Text] [Related]
4. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
[TBL] [Abstract][Full Text] [Related]
5. Is nalidixic acid screening still valid for the detection of reduced susceptibility of fluoroquinolone with Salmonella Typhi?
Irfan S; Jabeen K; Jilani UA; Ahmed B; Mehraj J; Ahsan T; Zafar A
J Infect Dev Ctries; 2012 Oct; 6(10):700-3. PubMed ID: 23103891
[TBL] [Abstract][Full Text] [Related]
6. Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi.
Ray P; Sharma J; Marak RS; Garg RK
Indian J Med Res; 2006 Jul; 124(1):105-8. PubMed ID: 16926465
[TBL] [Abstract][Full Text] [Related]
7. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility.
Albayrak F; Cokca F; Erdem B; Aysev AD
Int J Antimicrob Agents; 2004 Apr; 23(4):332-6. PubMed ID: 15081080
[TBL] [Abstract][Full Text] [Related]
9. Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey.
Ercis S; Erdem B; Hasçelik G; Gür D
Jpn J Infect Dis; 2006 Apr; 59(2):117-9. PubMed ID: 16632912
[TBL] [Abstract][Full Text] [Related]
10. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
Crump JA; Barrett TJ; Nelson JT; Angulo FJ
Clin Infect Dis; 2003 Jul; 37(1):75-81. PubMed ID: 12830411
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India.
Joshi S; Amarnath SK
Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):308-10. PubMed ID: 16950486
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
Biedenbach DJ; Toleman M; Walsh TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025
[TBL] [Abstract][Full Text] [Related]
13. Fluroquinolone resistance in typhoidal Salmonella and its detection by nalidixic acid disc diffusion.
Anjum P; Qureshi AH; Rafi S
J Pak Med Assoc; 2004 Jun; 54(6):295-301. PubMed ID: 15366793
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi.
Kim DM; Neupane GP; Jang SJ; Kim SH; Lee BK
Int J Antimicrob Agents; 2010 Aug; 36(2):155-8. PubMed ID: 20478696
[TBL] [Abstract][Full Text] [Related]
16. Nalidixic acid susceptibility test to screen ciprofloxacin resistance in Salmonella typhi.
Kapil A; Renuka ; Das B
Indian J Med Res; 2002 Feb; 115():49-54. PubMed ID: 12138664
[TBL] [Abstract][Full Text] [Related]
17. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.
Sekar U; Srikanth P; Kindo AJ; Babu VP; Ramasubramanian V
J Commun Dis; 2003 Sep; 35(3):162-9. PubMed ID: 15796408
[TBL] [Abstract][Full Text] [Related]
18. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
[TBL] [Abstract][Full Text] [Related]
19. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
[TBL] [Abstract][Full Text] [Related]
20. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.
Renuka K; Kapil A; Kabra SK; Wig N; Das BK; Prasad VV; Chaudhry R; Seth P
Microb Drug Resist; 2004; 10(2):146-53. PubMed ID: 15256030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
